InMed Pharmaceuticals Inc (NASDAQ:INM) achieved several risk-mitigating and value-adding milestones in IntegraSyn production approach and therapeutic programs. Eric A. Adams, CEO of InMed, said the company...
[ctt template=”12″ link=”wEp11″ via=”yes” ]InMed Pharmaceuticals Inc (OTCMKTS:IMLFF) Posts Net Loss Of CAD 2.81 million In Q3 2020[/ctt] InMed Pharmaceuticals Inc (OTCMKTS:IMLFF) has reported a net...